comparemela.com

Edda Sciutto News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vacuna anticovid UNAM no puede avanzar más rápido por infraestructura

El proyecto se encuentra en validar las pruebas preclínicas que demostraron que la vacuna es segura y produce inmunidad.

No podemos avanzar más rápido en vacuna anticovid por falta de infraestructura: investigadora de UNAM

No podemos avanzar más rápido en vacuna anticovid por falta de infraestructura: investigadora de UNAM
invdes.com.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from invdes.com.mx Daily Mail and Mail on Sunday newspapers.

This is how the creation of vaccines against COVID-19 in Latin America progresses

more than 300 candidates for vaccines against COVID-19 that had been registered all over the planet. Of these, at least twelve had already passed the third clinical phase, for which their use in humans had been approved. As expected, European countries, China and the United States were the ones that took advantage in the race to obtain a vaccine. Biologics such as those from Pfizer (United States), Sinovac (China), AstraZeneca (United Kingdom) and Sputnik V (Russia), have been the most popular worldwide. With its inoculation, the hope of reaching the beginning of the end of the pandemic was already a reality.

América Latina apura una vacuna propia Cuba, adelante; México avanza Pero no son los únicos

América Latina apura una vacuna propia Cuba, adelante; México avanza Pero no son los únicos
sinembargo.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sinembargo.mx Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.